Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Cell And Gene Therapy Clinical Trial Services Market From 2025 To 2034?
The cell and gene therapy clinical trial services market size has experienced substantial growth in recent times. Projections indicate this market will expand from $3.79 billion in 2024 to reach $4.18 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by several factors, including the rising incidence of chronic diseases, a greater need for effective therapies for rare genetic disorders, enhanced government investment in regenerative medicine research, a deeper comprehension of the molecular mechanisms of various ailments, and a heightened recognition of personalized medicine’s promise.
The cell and gene therapy clinical trial services market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $6.02 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include the escalating global prevalence of genetic and auto-immune conditions, increased investment from both public and private sectors in gene therapy research, the expanding integration of new technologies, and an uptick in genetic defects. Key trends for the forecast period encompass the integration of AI, the utilization of machine learning, the implementation of personalized medicine, continuous technological advancements, and the development of new gene therapies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15535&type=smp
What Are The Drivers Pushing New Developments In The Cell And Gene Therapy Clinical Trial Services Market?
The increasing prevalence of genetic conditions is anticipated to fuel expansion in the cell and gene therapy clinical trial services market in the future. These diseases stem from alterations in an individual’s DNA or genetic makeup. Several factors contribute to this rise, such as broader access to genetic screening, the emergence of genetic mutations, and the commonality of marriages between close relatives. To tackle the growing occurrence of genetic diseases, cell and gene therapy clinical trial services facilitate the creation of innovative treatments, customize therapies for specific patients, expedite the application of research into clinical settings, and broaden the therapeutic choices for those with genetic disorders. As an illustration, data from July 2022 by the Cystic Fibrosis (CF) Foundation, a US-based non-profit entity, indicated a notable increase in the population affected by cystic fibrosis. By 2022, nearly 40,000 children and adults in the United States were living with cystic fibrosis, with over 105,000 individuals diagnosed globally. Consequently, the escalating occurrence of genetic diseases is a key factor propelling the expansion of the cell and gene therapy clinical trial services market.
What Are The Major Segment Categories Driving The Cell And Gene Therapy Clinical Trial Services Market Growth?
The cell and gene therapy clinical trial servicesmarket covered in this report is segmented –
1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services
2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy
3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection
How Are Trends Influencing The Cell And Gene Therapy Clinical Trial Services Market?
Leading companies in the cell and gene therapy clinical trial services market are dedicating resources to integrate advanced technology, particularly customer relationship management systems, to enhance efficiency and gain a competitive edge. The customer relationship management system employed by cell and gene therapy clinical trial services organizes and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the entire clinical trial process. For example, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, introduced the Cell and Gene Therapy (CGT) Integration Hub, a platform designed to improve connectivity and streamline processes across the cell and gene therapy treatment pathway. This platform, supported by AmerisourceBergen’s customer relationship management (CRM) system, aims to simplify the path-to-care process, partly by offering physicians and patient services teams increased visibility across the therapy development and delivery. Featuring capabilities such as expedited benefits investigation, real-time status tracking, and proactive alerts, the CGT Integration Hub endeavors to simplify care coordination, reduce impediments, and enhance the overall experience for both patients and providers involved in delivering cell and gene therapies.
Which Industry Leaders Are Driving Innovation Across The Cell And Gene Therapy Clinical Trial Services Market?
Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Cell And Gene Therapy Clinical Trial Services Industry?
North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Cell And Gene Therapy Clinical Trial Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15535&type=smp
Browse Through More Reports Similar to the Global Cell And Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company
Cell Therapy Technologies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Cells Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Cell Surface Marker Detection Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-surface-marker-detection-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model